BHLHE40 and glioblastoma: Three genes (ARNTL, ARNTL2, BHLHE40) from MDSet (six merged datasets) could represent unfavorable prognostic factors for GBM, whereas CRY2, DBP and NR1D2 were associated with better prognosis (Figure 1A).